Compounds and compositions as protein kinase inhibitors
US8552002B2 · kind B2 · utility
77Cited by
1References
43Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 23, 2005 |
| Grant date | Oct 8, 2013 |
| Priority date | — |
| Expiry date | Jun 6, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I)wherein the substituents X1, R1, R2, R3 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, and a method for the treatment of such a disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.